• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Bausch + Lomb Corporation Common Shares (NY:BLCO)

    16.28 +0.11 (+0.68%)
    Streaming Delayed Price Updated: 10:25 AM EDT, Jul 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 99,994
    Open 16.38
    Bid (Size) 16.26 (300)
    Ask (Size) 16.33 (200)
    Prev. Close 16.17
    Today's Range 16.27 - 16.47
    52wk Range 13.09 - 18.91
    Shares Outstanding 353,800,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    3 Reasons to Avoid BLCO and 1 Stock to Buy Instead
    Over the past six months, Bausch + Lomb’s stock price fell to $15.99. Shareholders have lost 7% of their capital, which is disappointing considering the S&P ... 
    Via StockStory
    Topics Stocks
    News headline image
    Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States
    From Bausch + Lomb Corporation
    Via Business Wire

    Performance

    YTD
    -1.8%
    -1.8%
    1 Month
    -0.2%
    -0.2%
    3 Month
    +2.5%
    +2.5%
    6 Month
    -3.5%
    -3.5%
    1 Year
    +12.7%
    +12.7%

    More News

    Read More
    News headline image
    Why Bausch + Lomb (BLCO) Stock Is Trading Lower Today
    Via StockStory
    Topics Artificial Intelligence Economy Initial Public Offering
    News headline image
    Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
    From Bausch + Lomb
    Via Business Wire
    Bausch + Lomb Corp (NYSE:BLCO) Beats Q1 Estimates, Raises Full-Year Guidance ↗
    Via Chartmill
    News headline image
    Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care
    From Bausch + Lomb
    Via Business Wire
    News headline image
    Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    1 Unpopular Stock That Deserves a Second Chance and 2 We Brush Off
    Via StockStory
    News headline image
    New Bausch + Lomb Data Show that Addressing Dry Eye Symptoms is Associated with Improved Quality of Life, Including Lower Anxiety and Increased Self-Confidence
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    3 Small-Cap Stocks We Steer Clear Of
    Via StockStory
    News headline image
    1 Stock Under $50 to Own for Decades and 2 We Turn Down
    Via StockStory
    News headline image
    Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest
    Via StockStory
    News headline image
    Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    3 Profitable Stocks We’re Skeptical Of
    Via StockStory
    News headline image
    Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb Announces Second R&D “Teach-in” Webinar
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb (BLCO) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb (NYSE:BLCO) Posts Better-Than-Expected Sales In Q1 CY2026
    Via StockStory
    News headline image
    Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook
    From Bausch + Lomb Corporation
    Via Business Wire
    News headline image
    Bausch + Lomb (BLCO) Q1 Earnings Report Preview: What To Look For
    Via StockStory
    News headline image
    Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration
    From Bausch + Lomb Corporation
    Via Business Wire

    Frequently Asked Questions

    Is Bausch + Lomb Corporation Common Shares publicly traded?
    Yes, Bausch + Lomb Corporation Common Shares is publicly traded.
    What exchange does Bausch + Lomb Corporation Common Shares trade on?
    Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange
    What is the ticker symbol for Bausch + Lomb Corporation Common Shares?
    The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange
    What is the current price of Bausch + Lomb Corporation Common Shares?
    The current price of Bausch + Lomb Corporation Common Shares is 16.28
    When was Bausch + Lomb Corporation Common Shares last traded?
    The last trade of Bausch + Lomb Corporation Common Shares was at 07/27/26 10:25 AM ET
    What is the market capitalization of Bausch + Lomb Corporation Common Shares?
    The market capitalization of Bausch + Lomb Corporation Common Shares is 5.76B
    How many shares of Bausch + Lomb Corporation Common Shares are outstanding?
    Bausch + Lomb Corporation Common Shares has 6B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.